Nikolaus Beyer - Safe Orthopaedics Chief Commercial Officer
| ALSAF Stock | EUR 0.05 0 5.44% |
Insider
Nikolaus Beyer is Chief Commercial Officer of Safe Orthopaedics SA since 2020.
| Tenure | 4 years |
| Phone | 33 1 34 21 50 00 |
| Web | https://www.safeorthopaedics.com |
Safe Orthopaedics Management Efficiency
The company has return on total asset (ROA) of (0.2784) % which means that it has lost $0.2784 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of (639.4) %, meaning that it generated substantial loss on money invested by shareholders. Safe Orthopaedics' management efficiency ratios could be used to measure how well Safe Orthopaedics manages its routine affairs as well as how well it operates its assets and liabilities.Similar Executives
| Found 11 records | INSIDER Age | ||
| FFPM MBA | Biophytis SA | 52 | |
| Teylan | Biophytis SA | N/A | |
| Hugo Brugiere | Neovacs SA | N/A | |
| Benoit Canolle | Biophytis SA | 45 | |
| Julien Tellier | Acheter Louer | N/A | |
| Charlene Masson | Neovacs SA | N/A | |
| Philippe Rousseau | Biophytis SA | 52 | |
| Pierreme | Spineguard | N/A | |
| Stphane Bette | Spineguard | N/A | |
| Alexandre Courtoux | Neovacs SA | N/A | |
| Pr Zagury | Neovacs SA | N/A | |
Management Performance
| Return On Equity | -639.4 | |||
| Return On Asset | -0.28 |
Safe Orthopaedics Leadership Team
Elected by the shareholders, the Safe Orthopaedics' board of directors comprises two types of representatives: Safe Orthopaedics inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Safe. The board's role is to monitor Safe Orthopaedics' management team and ensure that shareholders' interests are well served. Safe Orthopaedics' inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Safe Orthopaedics' outside directors are responsible for providing unbiased perspectives on the board's policies.
| Michael DeMane, Independent Director | ||
| Philippe Petrou, Independent Director | ||
| Philippe Chene, Independent Director | ||
| FrancoisHenri Reynaud, Administrative and Financial Director, Director | ||
| Dominique Petit, Independent Director | ||
| Ismael Nujurally, Independent Director | ||
| Philippe Oak, Independent Director | ||
| Sven Claes, Director of Marketing | ||
| Stephanie Robert, Director of Quality and Reglemantary Affairs | ||
| MarieYvonne LandelMeunier, Independent Director | ||
| Katy Fraisse, Director of Human Resources | ||
| Thomas Droulout, Director, Technical Director | ||
| Nikolaus Beyer, Chief Commercial Officer | ||
| Adam Ross, Director Marketing | ||
| Anne Reiser, Independent Director | ||
| Sjors Hermans, Senior Vice President of Sales | ||
| Alain Coudray, Independent Chairman of the Board | ||
| Jochen Esser, Head Germany | ||
| Pierre Dumouchel, Chairman of the Board, Chief Executive Officer, Co-Founder | ||
| Nathalie Vazquez, HR Director |
Safe Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Safe Orthopaedics a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | -639.4 | |||
| Return On Asset | -0.28 | |||
| Profit Margin | (1.23) % | |||
| Operating Margin | (1.35) % | |||
| Current Valuation | 10.42 M | |||
| Shares Outstanding | 79.68 M | |||
| Price To Book | 0.40 X | |||
| Price To Sales | 0.01 X | |||
| Revenue | 4.56 M | |||
| Gross Profit | 2.57 M |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Additional Tools for Safe Stock Analysis
When running Safe Orthopaedics' price analysis, check to measure Safe Orthopaedics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Safe Orthopaedics is operating at the current time. Most of Safe Orthopaedics' value examination focuses on studying past and present price action to predict the probability of Safe Orthopaedics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Safe Orthopaedics' price. Additionally, you may evaluate how the addition of Safe Orthopaedics to your portfolios can decrease your overall portfolio volatility.